Pluripotent stem cells induced from mouse somatic cells by small-molecule compounds P Hou, Y Li, X Zhang, C Liu, J Guan, H Li, T Zhao, J Ye, W Yang, K Liu, ... Science 341 (6146), 651-654, 2013 | 1670 | 2013 |
Generation of induced pluripotent stem cells from adult rhesus monkey fibroblasts H Liu, F Zhu, J Yong, P Zhang, P Hou, H Li, W Jiang, J Cai, M Liu, K Cui, ... Cell stem cell 3 (6), 587-590, 2008 | 664 | 2008 |
Two supporting factors greatly improve the efficiency of human iPSC generation Y Zhao, X Yin, H Qin, F Zhu, H Liu, W Yang, Q Zhang, C Xiang, P Hou, ... Cell stem cell 3 (5), 475-479, 2008 | 636 | 2008 |
Targeting YAP-dependent MDSC infiltration impairs tumor progression G Wang, X Lu, P Dey, P Deng, CC Wu, S Jiang, Z Fang, K Zhao, ... Cancer discovery 6 (1), 80-95, 2016 | 512 | 2016 |
Generation of iPSCs from mouse fibroblasts with a single gene, Oct4, and small molecules Y Li, Q Zhang, X Yin, W Yang, Y Du, P Hou, J Ge, C Liu, W Zhang, ... Cell research 21 (1), 196-204, 2011 | 411 | 2011 |
Claudin-6 and claudin-9 function as additional coreceptors for hepatitis C virus A Zheng, F Yuan, Y Li, F Zhu, P Hou, J Li, X Song, M Ding, H Deng Journal of virology 81 (22), 12465-12471, 2007 | 296 | 2007 |
Syndecan 1 is a critical mediator of macropinocytosis in pancreatic cancer W Yao, JL Rose, W Wang, S Seth, H Jiang, A Taguchi, J Liu, L Yan, ... Nature 568 (7752), 410-414, 2019 | 169 | 2019 |
Tumor microenvironment remodeling enables bypass of oncogenic KRAS dependency in pancreatic cancer P Hou, A Kapoor, Q Zhang, J Li, CJ Wu, J Li, Z Lan, M Tang, X Ma, ... Cancer discovery 10 (7), 1058-1077, 2020 | 102 | 2020 |
Targeting YAP-dependent MDSC infiltration impairs tumor progression. Cancer Discov. 2016; 6: 80–95. doi: 10.1158/2159-8290 G Wang, X Lu, P Dey, P Deng, CC Wu, S Jiang, Z Fang, K Zhao, ... CD-15-0224.[Europe PMC free article][Abstract][CrossRef][Google Scholar], 0 | 98 | |
USP21 deubiquitinase promotes pancreas cancer cell stemness via Wnt pathway activation P Hou, X Ma, Q Zhang, CJ Wu, W Liao, J Li, H Wang, J Zhao, X Zhou, ... Genes & development 33 (19-20), 1361-1366, 2019 | 78 | 2019 |
Telomere dysfunction activates YAP1 to drive tissue inflammation D Chakravarti, B Hu, X Mao, A Rashid, J Li, J Li, W Liao, EM Whitley, ... Nature communications 11 (1), 4766, 2020 | 67 | 2020 |
Targeting T cell checkpoints 41BB and LAG3 and myeloid cell CXCR1/CXCR2 results in antitumor immunity and durable response in pancreatic cancer P Gulhati, A Schalck, S Jiang, X Shang, CJ Wu, P Hou, SH Ruiz, LS Soto, ... Nature cancer 4 (1), 62-80, 2023 | 50 | 2023 |
Role of the tumor microenvironment in regulating pancreatic cancer therapy resistance D Deng, R Patel, CY Chiang, P Hou Cells 11 (19), 2952, 2022 | 27 | 2022 |
P4HA2-induced prolyl hydroxylation suppresses YAP1-mediated prostate cancer cell migration, invasion, and metastasis M Zhu, R Peng, X Liang, Z Lan, M Tang, P Hou, JH Song, CSL Mak, ... Oncogene 40 (41), 6049-6056, 2021 | 24 | 2021 |
USP21 deubiquitinase elevates macropinocytosis to enable oncogenic KRAS bypass in pancreatic cancer P Hou, X Ma, Z Yang, Q Zhang, CJ Wu, J Li, L Tan, W Yao, L Yan, X Zhou, ... Genes & development 35 (19-20), 1327-1332, 2021 | 23 | 2021 |
Tumor microenvironment remodeling enables bypass of oncogenic KRAS dependency in pancreatic cancer. Cancer Discov. 2020; 10: 1058–1077. doi: 10.1158/2159-8290 P Hou, A Kapoor, Q Zhang, J Li, CJ Wu, J Li, Z Lan, M Tang, X Ma, ... CD-19-0597.[Europe PMC free article][Abstract][CrossRef][Google Scholar], 0 | 16 | |
Conquering oncogenic KRAS and its bypass mechanisms P Hou, YA Wang Theranostics 12 (13), 5691, 2022 | 8 | 2022 |
Compositions and methods for reprograming non-pluripotent cells into pluripotent stem cells H Deng, Y Zhao, P Hou, Y Li, X Zhang, C Liu, J Guan, H Li US Patent 9,982,237, 2018 | 5 | 2018 |
Yap1 Hydroxylation Suppress Prostate Cancer Metastasis M Zhu, R Peng, X Liang, Z Lan, M Tang, P Hou, JH Song, CSL Mak, ... | | 2022 |
Abstract IA24: YAP in cancer and inflammation G Wang, X Lu, D Chakravarti, A Kapoor, W Yao, H Ying, P Dey, C Wu, ... Molecular Cancer Research 18 (8_Supplement), IA24-IA24, 2020 | | 2020 |